Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron ...
Source LinkMorgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to Overweight. Regeneron ...
Source Link
Comments